All sponsors

Hinova Pharmaceuticals Inc.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS5
PHASE 3 / 2-32
RECRUITING3
READOUTS ≤12 MONTHS0
Open Hinova Pharmaceuticals Inc. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
HC-1119
NCT03851640
P3RecruitingMCRPC4172025-09
HP568
NCT06757335
P1/2Not yet recruitingBreast Cancer2042026-01-31
HP518 - Dose Escalation
NCT06155084
P1/2RecruitingMetastatic Castration-resistant Prostate Cancer842026-03 (-4 mo)
NASH/MASH
NCT07308548
P2RecruitingNAFLD (Non-alcoholic Fatty Liver Disease)802026-08-13
Deutenzalutamide Soft Capsules + ADT
NCT07875881
P3Not yet recruitingHigh Risk Biochemical Recurrence (BCR); Deutenzalutamide Soft Capsules10442029-12-31